Testing effectiveness (Phase 2)UnknownNCT05466175What this trial is testingOlverembatinib in the Treatment of Ph+ ALLWho this might be right forPhiladelphia-Positive ALL Chen Suning 55
Testing effectiveness (Phase 2)Study completedNCT00702403What this trial is testingNilotinib and Imatinib Mesylate After Donor Stem Cell Transplant in Treating Patients With ALL or CMLWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionBlastic Phase Chronic Myelogenous Leukemia+11 more Fred Hutchinson Cancer Center 40
Early research (Phase 1)Study completedNCT00316953What this trial is testingDasatinib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Did Not Respond to Imatinib MesylateWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaBlastic Phase Chronic Myelogenous LeukemiaChildhood Chronic Myelogenous Leukemia+5 more National Cancer Institute (NCI) 48
Not applicableEnded earlyNCT00608517What this trial is testingTreatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate MofetilWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+2 more Vanderbilt-Ingram Cancer Center 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT04475731What this trial is testingPonatinib in Adult Ph+ ALL Patients With MRD Positivity or Hematological RelapseWho this might be right forPhiladelphia-Positive ALLAcute Lymphoblastic Leukemia, in Relapse Gruppo Italiano Malattie EMatologiche dell'Adulto 67
Large-scale testing (Phase 3)Active Not RecruitingNCT04722848What this trial is testingSequential Treatment With Ponatinib and Blinatumomab vs Chemotherapy and Imatinib in Newly Diagnosed Adult Ph+ ALLWho this might be right forAcute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)ALL, AdultPhiladelphia-Positive ALL Gruppo Italiano Malattie EMatologiche dell'Adulto 236
Testing effectiveness (Phase 2)Looking for participantsNCT06220487What this trial is testingA Single-arm, Open-label Study of Olverembatinib, CD3/CD19 Bispecific T-cell Engager, and Chidamide in Patients With Newly Diagnosed Ph+ALLWho this might be right forAcute Lymphoblastic LeukemiaPhiladelphia ChromosomePhiladelphia-Positive ALL+2 more Nanfang Hospital, Southern Medical University 67
Not applicableNot Yet RecruitingNCT06175702What this trial is testingTreatment Protocol for Newky Diagnosed Adult Ph Positive ALLWho this might be right forLymphoblastic LeukemiaPhiladelphia-Positive ALLAdult ALL PETHEMA Foundation 150
Testing effectiveness (Phase 2)Study completedNCT00244829What this trial is testingImatinib Mesylate After a Donor Stem Cell Transplant in Treating Patients With Philadelphia Chromosome-Positive LeukemiaWho this might be right forLeukemia Fred Hutchinson Cancer Center
Not applicableEnded earlyNCT00008216What this trial is testingBlood Stem Cell Transplant in Treating Patients With Hematologic CancerWho this might be right forAdult Langerhans Cell HistiocytosisChildhood Langerhans Cell HistiocytosisLeukemia+4 more Columbia University 48
Testing effectiveness (Phase 2)Study completedNCT00061945What this trial is testingAlemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic LeukemiaWho this might be right forAcute Undifferentiated LeukemiaB-cell Adult Acute Lymphoblastic LeukemiaB-cell Childhood Acute Lymphoblastic Leukemia+11 more National Cancer Institute (NCI) 302
Not applicableUnknownNCT01185886What this trial is testingStudy of Blood and Tissue Samples in Children With Newly Diagnosed Acute Lymphoblastic LeukemiaWho this might be right forLeukemiaLymphoma European Organisation for Research and Treatment of Cancer - EORTC 1,200
Testing effectiveness (Phase 2)Study completedNCT02228096What this trial is testingStudy of Efficacy and Safety of CTL019 in Pediatric ALL PatientsWho this might be right forB-cell Acute Lymphoblastic LeukemiaRelapsed B-cell Acute Lymphoblastic LeukemiaRefractory B-cell Acute Lymphoblastic Leukemia Novartis Pharmaceuticals 75
Large-scale testing (Phase 3)Study completedNCT00720109What this trial is testingDasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaWho this might be right forAcute Lymphoblastic LeukemiaAdult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 National Cancer Institute (NCI) 63
Early research (Phase 1)Ended earlyNCT02819804What this trial is testingNivolumab and Dasatinib in Treating Patients With Relapsed or Refractory Philadelphia Chromosome Positive Acute Lymphoblastic LeukemiaWho this might be right forB Acute Lymphoblastic Leukemia With t(9;22)(q34;q11.2); BCR-ABL1Recurrent Adult Acute Lymphoblastic LeukemiaRecurrent Childhood Acute Lymphoblastic Leukemia+2 more Northwestern University 1
Large-scale testing (Phase 3)Looking for participantsNCT07152041What this trial is testingNewly-diagnosed Pediatric Ph-positive B-ALL ProtocolWho this might be right forAcute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+)Childhood Leukemia, Acute Lymphoblastic Institute of Hematology & Blood Diseases Hospital, China 150
Early research (Phase 1)Looking for participantsNCT06287528What this trial is testing19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL)Who this might be right forPhiladelphia-Negative ALLPhiladelphia-Positive ALLRelapsed ALL, Adult+3 more Memorial Sloan Kettering Cancer Center 18
Early research (Phase 1)UnknownNCT05495035What this trial is testingStudy for Safety and Efficacy of Olverembatinib Combined With APG-2575 in Children With Relapsed/Refractory Ph + ALLWho this might be right forLymphoblastic Leukemia, Acute, ChildhoodLeukemia, Lymphoblastic, Acute, Philadelphia-PositiveRelapsed Leukemia+1 more Institute of Hematology & Blood Diseases Hospital, China 22
Early research (Phase 1)Active Not RecruitingNCT03241940What this trial is testingStudy of CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults w/ Recurrent or Refractory B Cell MalignanciesWho this might be right forB Acute Lymphoblastic LeukemiaCD19 PositiveMinimal Residual Disease+4 more Stanford University 33
Testing effectiveness (Phase 2)Study completedNCT01445080What this trial is testingSorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or LeukemiaWho this might be right forBlastic PhaseChildhood Acute Promyelocytic Leukemia With PML-RARAChildhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive+7 more National Cancer Institute (NCI) 70